SYNGENE
Invest with MTF
Invest Now
Invest in Syngene International with 3.41X leverage
Syngene International live price: ₹408.15. It opened at ₹409 vs previous close ₹409; intraday high/low: ₹417/₹406. The 50 & 200 DMA stand at ₹489.00/₹602.16.
Syngene International Performance
- Low
- ₹406
- High
- ₹417
- 52 Week Low
- ₹387
- 52 Week High
- ₹760
- Open Price₹409
- Previous Close₹409
- Volume614,892
- 50 DMA₹489.00
- 100 DMA₹545.86
- 200 DMA₹602.16
Investment Returns
- Over 1 Month -10.32%
- Over 3 Month -36.31%
- Over 6 Month -38.25%
- Over 1 Year -40.14%
Smart Investing Starts Here Start SIP with Syngene International for Steady Growth!
Syngene International Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 46.7
- PEG Ratio
- -1.6
- Market Cap Cr
- 16,446
- P/B Ratio
- 3.5
- Average True Range
- 13.55
- EPS
- 10.16
- Dividend Yield
- 0.3
- MACD Signal
- -30.6
- RSI
- 27.53
- MFI
- 39.92
Syngene International Financials
Syngene International Technicals
EMA & SMA
Current Price
₹408.15
-1.15
(-0.28%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹430.18
- 50 Day
- ₹489.00
- 100 Day
- ₹545.86
- 200 Day
- ₹602.16
Resistance and Support
410.17
- R3 426.18
- R2 421.52
- R1 414.83
- S1 403.48
- S2 398.82
- S3 392.13
Syngene International Corporate Actions - Bonus, Splits, Dividends
Syngene International F&O
About Syngene International
- NSE Symbol
- SYNGENE
- BSE Symbol
- 539268
- Managing Director & CEO
- Mr. Peter Bains
- ISIN
- INE398R01022
Similar Stocks to Syngene International
Syngene International FAQs
Syngene International share price is ₹408 As on 12 March, 2026 | 07:35
The Market Cap of Syngene International is ₹16446 Cr As on 12 March, 2026 | 07:35
The P/E ratio of Syngene International is 46.7 As on 12 March, 2026 | 07:35
The PB ratio of Syngene International is 3.5 As on 12 March, 2026 | 07:35
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.